Literature DB >> 1940887

Three forms of somatization in primary care: prevalence, co-occurrence, and sociodemographic characteristics.

L J Kirmayer1, J M Robbins.   

Abstract

Three definitions of somatization were operationalized: (a) high levels of functional somatic distress, measured by the Somatic Symptom Index (SSI) of the Diagnostic Interview Schedule; (b) hypochondriasis measured by high scores on a measure of illness worry in the absence of evidence for serious illness; and (c) exclusively somatic clinical presentations among patients with current major depression or anxiety. Of 685 patients attending two family medicine clinics, 26.3% met criteria for one or more forms of somatization. While DSM-III somatization disorder had a prevalence of only 1% in this population, 16.6% of the patients met abridged criteria for subsyndromal somatization disorder (SSI 4,6). Hypochondriacal worry had a prevalence of 7.7% in the clinic sample. Somatized presentations of current major depression or anxiety disorder had a prevalence of 8%. The three forms of somatization were associated with different sociodemographic and illness behavior characteristics. A majority of patients met criteria for only one type of somatization, suggesting that distinct pathogenic processes may be involved in each of the three types.

Entities:  

Mesh:

Year:  1991        PMID: 1940887     DOI: 10.1097/00005053-199111000-00001

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  36 in total

Review 1.  Toward a model of social course in chronic illness: the example of chronic fatigue syndrome.

Authors:  N C Ware
Journal:  Cult Med Psychiatry       Date:  1999-09

2.  The phenomenon of somatization among community Chinese Americans.

Authors:  Winnie W S Mak; Nolan W S Zane
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-12       Impact factor: 4.328

3.  Health anxiety symptoms in children and adolescents diagnosed with OCD.

Authors:  Anna Villadsen; Mette V Thorgaard; Katja A Hybel; Jens Søndergaard Jensen; Per H Thomsen; Charlotte U Rask
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-06-29       Impact factor: 4.785

Review 4.  Somatoform disorders and medically unexplained symptoms in primary care.

Authors:  Heidemarie Haller; Holger Cramer; Romy Lauche; Gustav Dobos
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

5.  Prevalence and correlates of somatoform disorders in the elderly: Results of a European study.

Authors:  Maria Christina Dehoust; Holger Schulz; Martin Härter; Jana Volkert; Susanne Sehner; Anna Drabik; Karl Wegscheider; Alessandra Canuto; Kerstin Weber; Mike Crawford; Alan Quirk; Luigi Grassi; Chiara DaRonch; Manuel Munoz; Berta Ausin; Anna Santos-Olmo; Arieh Shalev; Ora Rotenstein; Yael Hershkowitz; Jens Strehle; Hans-Ulrich Wittchen; Sylke Andreas
Journal:  Int J Methods Psychiatr Res       Date:  2017-02-01       Impact factor: 4.035

6.  Health status in sickle cell disease: examining the roles of pain coping strategies, somatic awareness, and negative affectivity.

Authors:  J D McCrae; M A Lumley
Journal:  J Behav Med       Date:  1998-02

7.  Epidemiology of somatoform disorders: a community survey in Florence.

Authors:  C Faravelli; S Salvatori; F Galassi; L Aiazzi; C Drei; P Cabras
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-01       Impact factor: 4.328

Review 8.  Somatic symptom reporting in women and men.

Authors:  A J Barsky; H M Peekna; J F Borus
Journal:  J Gen Intern Med       Date:  2001-04       Impact factor: 5.128

9.  S3 Guideline "Management of Patients with Non-Specific, Functional and Somatoform Physical Complaints" - What is Important for Gynaecological Practice?

Authors:  F Siedentopf; C Hausteiner-Wiehle
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-03       Impact factor: 2.915

10.  Non-specific, functional, and somatoform bodily complaints.

Authors:  Rainer Schaefert; Constanze Hausteiner-Wiehle; Winfried Häuser; Joram Ronel; Markus Herrmann; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2012-11-23       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.